Revised terms to increase certainty in issuance, propel 5G growth
23Q3业绩不及预期,储能需求持续承压,盈利水平小幅修复
2023年三季报业绩点评:短期调整经营节奏,着眼长期质量发展
Peptide business becoming a new growth driver
3Q rev/np +3%/59%; cost cut was key to profit growth